# GSI Technology Inc: financial statements, quarterly

GSIT · Nasdaq · CIK 1126741 · [Technology](/sectors/technology.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/gsit.md) · [Financials](/companies/gsit/financials.md) · [Filings](/companies/gsit/filings.md) · [Insiders](/companies/gsit/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gsit/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [5,708](/filings/0001558370-24-014139.md) | [5,318](/filings/0001558370-25-000749.md) | [5,152 d](/filings/0001104659-26-070962.md) | [4,671](/filings/0001558370-25-010923.md) | [4,550](/filings/0001104659-25-108467.md) | [5,414](/filings/0001104659-26-011501.md) | [5,883 d](/filings/0001104659-26-070962.md) | [6,283](/filings/0001104659-26-094044.md) | [6,444](/filings/0001104659-25-108467.md) | [6,076](/filings/0001104659-26-011501.md) | [6,319 d](/filings/0001104659-26-070962.md) | [6,312](/filings/0001104659-26-094044.md) |
| Cost of revenue | $k | [2,587](/filings/0001558370-24-014139.md) | [2,343](/filings/0001558370-25-000749.md) | [2,494 d](/filings/0001104659-26-070962.md) | [2,510](/filings/0001558370-25-010923.md) | [2,793](/filings/0001104659-25-108467.md) | [2,491](/filings/0001104659-26-011501.md) | [2,584 d](/filings/0001104659-26-070962.md) | [2,632](/filings/0001104659-26-094044.md) | [2,911](/filings/0001104659-25-108467.md) | [2,876](/filings/0001104659-26-011501.md) | [3,008 d](/filings/0001104659-26-070962.md) | [2,943](/filings/0001104659-26-094044.md) |
| Gross profit | $k | [3,121](/filings/0001558370-24-014139.md) | [2,975](/filings/0001558370-25-000749.md) | [2,658 d](/filings/0001104659-26-070962.md) | [2,161](/filings/0001558370-25-010923.md) | [1,757](/filings/0001104659-25-108467.md) | [2,923](/filings/0001104659-26-011501.md) | [3,299 d](/filings/0001104659-26-070962.md) | [3,651](/filings/0001104659-26-094044.md) | [3,533](/filings/0001104659-25-108467.md) | [3,200](/filings/0001104659-26-011501.md) | [3,311 d](/filings/0001104659-26-070962.md) | [3,369](/filings/0001104659-26-094044.md) |
| Research and development | $k | [4,691](/filings/0001558370-24-014139.md) | [6,976](/filings/0001558370-25-000749.md) | [4,818 d](/filings/0001104659-26-070962.md) | [4,214](/filings/0001558370-25-010923.md) | [4,788](/filings/0001104659-25-108467.md) | [4,037](/filings/0001104659-26-011501.md) | [2,966 d](/filings/0001104659-26-070962.md) | [3,097](/filings/0001104659-26-094044.md) | [3,768](/filings/0001104659-25-108467.md) | [7,457](/filings/0001104659-26-011501.md) | [5,625 d](/filings/0001104659-26-070962.md) | [5,899](/filings/0001104659-26-094044.md) |
| Selling, general and administrative | $k | [2,523](/filings/0001558370-24-014139.md) | [2,684](/filings/0001558370-25-000749.md) | [2,354 d](/filings/0001104659-26-070962.md) | [2,604](/filings/0001558370-25-010923.md) | [2,553](/filings/0001104659-25-108467.md) | [2,997](/filings/0001104659-26-011501.md) | [2,609 d](/filings/0001104659-26-070962.md) | [2,730](/filings/0001104659-26-094044.md) | [2,952](/filings/0001104659-25-108467.md) | [2,649](/filings/0001104659-26-011501.md) | [2,894 d](/filings/0001104659-26-070962.md) | [2,855](/filings/0001104659-26-094044.md) |
| Operating income | $k | [(4,093)](/filings/0001558370-24-014139.md) | [(6,685)](/filings/0001558370-25-000749.md) | [(4,514) d](/filings/0001104659-26-070962.md) | [1,080](/filings/0001558370-25-010923.md) | [(5,584)](/filings/0001104659-25-108467.md) | [(4,055)](/filings/0001104659-26-011501.md) | [(2,276) d](/filings/0001104659-26-070962.md) | [(2,176)](/filings/0001104659-26-094044.md) | [(3,187)](/filings/0001104659-25-108467.md) | [(6,906)](/filings/0001104659-26-011501.md) | [(5,208) d](/filings/0001104659-26-070962.md) | [(5,385)](/filings/0001104659-26-094044.md) |
| Income tax | $k | [33.0](/filings/0001558370-24-014139.md) | [71.0](/filings/0001558370-25-000749.md) | [(85.0) d](/filings/0001104659-26-070962.md) | [57.0](/filings/0001558370-25-010923.md) | [23.0](/filings/0001104659-25-108467.md) | [44.0](/filings/0001104659-26-011501.md) | [6.0 d](/filings/0001104659-26-070962.md) | [54.0](/filings/0001104659-26-094044.md) | [41.0](/filings/0001104659-25-108467.md) | [(251)](/filings/0001104659-26-011501.md) | [24.0 d](/filings/0001104659-26-070962.md) | [(76.0)](/filings/0001104659-26-094044.md) |
| Net income | $k | [(4,055)](/filings/0001558370-24-014139.md) | [(6,601)](/filings/0001558370-25-000749.md) | [(4,321) d](/filings/0001104659-26-070962.md) | [1,078](/filings/0001558370-25-010923.md) | [(5,458)](/filings/0001104659-25-108467.md) | [(4,029)](/filings/0001104659-26-011501.md) | [(2,230) d](/filings/0001104659-26-070962.md) | [(2,217)](/filings/0001104659-26-094044.md) | [(3,185)](/filings/0001104659-25-108467.md) | [(3,020)](/filings/0001104659-26-011501.md) | [(4,824) d](/filings/0001104659-26-070962.md) | [(4,792)](/filings/0001104659-26-094044.md) |
| Diluted EPS | $ per share | [(0.16)](/filings/0001558370-24-014139.md) | [(0.26)](/filings/0001558370-25-000749.md) | not reported | [0.04](/filings/0001558370-25-010923.md) | [(0.21)](/filings/0001104659-25-108467.md) | [(0.16)](/filings/0001104659-26-011501.md) | not reported | [(0.08)](/filings/0001104659-26-094044.md) | [(0.11)](/filings/0001104659-25-108467.md) | [(0.09)](/filings/0001104659-26-011501.md) | not reported | [(0.13)](/filings/0001104659-26-094044.md) |
| Basic EPS | $ per share | [(0.16)](/filings/0001558370-24-014139.md) | [(0.26)](/filings/0001558370-25-000749.md) | not reported | [0.04](/filings/0001558370-25-010923.md) | [(0.21)](/filings/0001104659-25-108467.md) | [(0.16)](/filings/0001104659-26-011501.md) | not reported | [(0.08)](/filings/0001104659-26-094044.md) | [(0.11)](/filings/0001104659-25-108467.md) | [(0.09)](/filings/0001104659-26-011501.md) | not reported | [(0.13)](/filings/0001104659-26-094044.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [24.7](/filings/0001558370-23-018266.md) | [21.6](/filings/0001558370-24-000715.md) | [14.4](/filings/0001558370-25-008723.md) | [21.8](/filings/0001558370-24-010722.md) | [18.4](/filings/0001558370-24-014139.md) | [15.1](/filings/0001558370-25-000749.md) | [13.4](/filings/0001104659-26-070962.md) | [22.7](/filings/0001558370-25-010923.md) | [25.3](/filings/0001104659-25-108467.md) | [70.7](/filings/0001104659-26-011501.md) | [67.2](/filings/0001104659-26-094044.md) | [77.0](/filings/0001104659-26-094044.md) |
| Current assets | $m | [35.2](/filings/0001558370-23-018266.md) | [31.5](/filings/0001558370-24-000715.md) | [30.1](/filings/0001558370-25-008723.md) | [31.1](/filings/0001558370-24-010722.md) | [26.6](/filings/0001558370-24-014139.md) | [23.8](/filings/0001558370-25-000749.md) | [23.5](/filings/0001104659-26-070962.md) | [31.1](/filings/0001558370-25-010923.md) | [32.7](/filings/0001104659-25-108467.md) | [79.3](/filings/0001104659-26-011501.md) | [79.2](/filings/0001104659-26-094044.md) | [89.8](/filings/0001104659-26-094044.md) |
| Total assets | $m | [53.1](/filings/0001558370-23-018266.md) | [49.1](/filings/0001558370-24-000715.md) | [42.5](/filings/0001558370-25-008723.md) | [52.3](/filings/0001558370-24-010722.md) | [47.4](/filings/0001558370-24-014139.md) | [44.1](/filings/0001558370-25-000749.md) | [43.3](/filings/0001104659-26-070962.md) | [50.5](/filings/0001558370-25-010923.md) | [52.0](/filings/0001104659-25-108467.md) | [98.5](/filings/0001104659-26-011501.md) | [98.0](/filings/0001104659-26-094044.md) | [109](/filings/0001104659-26-094044.md) |
| Current liabilities | $m | [6.4](/filings/0001558370-23-018266.md) | [8.4](/filings/0001558370-24-000715.md) | [5.4](/filings/0001558370-25-008723.md) | [5.4](/filings/0001558370-24-010722.md) | [5.5](/filings/0001558370-24-014139.md) | [5.9](/filings/0001558370-25-000749.md) | [7.1](/filings/0001104659-26-070962.md) | [5.4](/filings/0001558370-25-010923.md) | [6.0](/filings/0001104659-25-108467.md) | [7.6](/filings/0001104659-26-011501.md) | [9.2](/filings/0001104659-26-094044.md) | [9.8](/filings/0001104659-26-094044.md) |
| Total liabilities | $m | [7.7](/filings/0001558370-23-018266.md) | [9.5](/filings/0001558370-24-000715.md) | [6.5](/filings/0001558370-25-008723.md) | [14.3](/filings/0001558370-24-010722.md) | [14.1](/filings/0001558370-24-014139.md) | [14.2](/filings/0001558370-25-000749.md) | [15.1](/filings/0001104659-26-070962.md) | [13.1](/filings/0001558370-25-010923.md) | [13.4](/filings/0001104659-25-108467.md) | [14.8](/filings/0001104659-26-011501.md) | [16.2](/filings/0001104659-26-094044.md) | [16.6](/filings/0001104659-26-094044.md) |
| Shareholders' equity | $m | [45.4](/filings/0001558370-25-000749.md) | [39.6](/filings/0001558370-25-000749.md) | [36.0](/filings/0001104659-26-070962.md) | [38.0](/filings/0001104659-25-108467.md) | [33.3](/filings/0001104659-26-011501.md) | [29.9](/filings/0001104659-26-011501.md) | [28.2](/filings/0001104659-26-094044.md) | [37.4](/filings/0001104659-26-094044.md) | [38.6](/filings/0001104659-26-011501.md) | [83.6](/filings/0001104659-26-011501.md) | [81.8](/filings/0001104659-26-094044.md) | [91.9](/filings/0001104659-26-094044.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(2,564) d](/filings/0001558370-24-014139.md) | [(3,906) d](/filings/0001558370-25-000749.md) | [(7,149) d](/filings/0001104659-26-070962.md) | [(4,264)](/filings/0001558370-25-010923.md) | [(3,480) d](/filings/0001104659-25-108467.md) | [(3,573) d](/filings/0001104659-26-011501.md) | [(1,658) d](/filings/0001104659-26-070962.md) | [(1,712)](/filings/0001104659-26-094044.md) | [(887) d](/filings/0001104659-25-108467.md) | [(7,872) d](/filings/0001104659-26-011501.md) | [(5,452) d](/filings/0001104659-26-070962.md) | [(3,858)](/filings/0001104659-26-094044.md) |
| Capital expenditure | $k | [17.0 d](/filings/0001558370-24-014139.md) | [10.0 d](/filings/0001558370-25-000749.md) | [11.0 d](/filings/0001104659-26-070962.md) | [32.0](/filings/0001558370-25-010923.md) | [6.0 d](/filings/0001104659-25-108467.md) | [3.0 d](/filings/0001104659-26-011501.md) | [4.0 d](/filings/0001104659-26-070962.md) | [21.0](/filings/0001104659-26-094044.md) | [19.0 d](/filings/0001104659-25-108467.md) | [296 d](/filings/0001104659-26-011501.md) | [150 d](/filings/0001104659-26-070962.md) | [358](/filings/0001104659-26-094044.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [24.6](/filings/0001558370-23-018266.md) | [24.6](/filings/0001558370-24-000715.md) | [24.9](/filings/0001558370-24-010722.md) | [25.2](/filings/0001558370-24-014139.md) | [25.3](/filings/0001558370-25-000749.md) | [25.7](/filings/0001558370-25-010923.md) | [25.5](/filings/0001104659-25-108467.md) | [25.5](/filings/0001104659-26-011501.md) | [27.0](/filings/0001104659-26-094044.md) | [29.6](/filings/0001104659-25-108467.md) | [34.5](/filings/0001104659-26-011501.md) | [37.3](/filings/0001104659-26-094044.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 38,432,590 at 2026-07-31, from the cover of the [10-Q filed 2026-08-11](/filings/0001104659-26-094044.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.